Moon Hyun Duk, Nakajima Katsuyuki, Kamiyama Kiyoshi, Takanashi Kunihiko, Sakurabayashi Ikunosuke, Nagamine Takeaki
School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Shouwa-machi, Maebashi, Gunma 371-8514, Japan.
Clin Chim Acta. 2008 Dec;398(1-2):99-104. doi: 10.1016/j.cca.2008.08.021. Epub 2008 Sep 3.
Either a decrease of cholesteryl ester transfer protein (CETP) or an increase of angiopoietin-like protein 3 (ANGPTL3) in plasma has been shown to increase HDL-cholesterol (HDL-C) levels. However, as yet, it is not known which protein is more strongly associated with the modulation of HDL in the Japanese hyperalphalipoproteinemic (HALT) subjects.
The serum concentration of ANGPTL3 and CETP, together with total cholesterol (TC), triglycerides (TG), adiponectin and ApoE phenotypes were determined in three groups with different HDL-C concentrations: low, <40 mg/dl (n=51); normal, 40-90 mg/dl (n=126) and high, >90 mg/dl (n=89) in the average Japanese population.
The normal range (mean+/-2SD) of serum ANGPTL3 (218+/-144 ng/ml) and CETP (1.29+/-0.90 microg/ml) were determined in cases with 40-90 mg/dl HDL-C concentration. The frequency of abnormally high ANGPTL3 cases (>362 ng/ml) were found to be significantly greater (44%) compared with those of low CETP cases (<0.39 microg/ml, 4.5%) in HALT cases (>90 mg/dl). ANGPTL3 showed a high correlation with HDL-C (r=0.67, P<0.0001) and adiponectin (r=0.57, P<0.0001), but not with CETP.
In average Japanese population, abnormally higher frequency of increased ANGPTL3 prevail in HALT cases as compared with cases with low CETP. These findings suggest that ANGPTL3, the inhibitor of endothelial lipase, may be more strongly associated with increased HDL-C rather than CETP in plasma. Accordingly, ANGPTL3 seems to be a better target for the modulation of HDL-C.
血浆中胆固醇酯转运蛋白(CETP)减少或血管生成素样蛋白3(ANGPTL3)增加均已显示可提高高密度脂蛋白胆固醇(HDL-C)水平。然而,迄今为止,尚不清楚在日本高α脂蛋白血症(HALT)受试者中,哪种蛋白与HDL的调节更为密切相关。
在平均日本人群中,对三组不同HDL-C浓度的人群测定血清ANGPTL3和CETP浓度,以及总胆固醇(TC)、甘油三酯(TG)、脂联素和载脂蛋白E表型:低HDL-C组,<40mg/dl(n=51);正常HDL-C组,40-90mg/dl(n=126);高HDL-C组,>90mg/dl(n=89)。
在HDL-C浓度为40-90mg/dl的病例中,测定了血清ANGPTL3(218±144ng/ml)和CETP(1.29±0.90μg/ml)的正常范围(均值±2SD)。在HALT病例(>90mg/dl)中,发现ANGPTL3异常高值病例(>362ng/ml)的频率(44%)显著高于低CETP病例(<0.39μg/ml,4.5%)。ANGPTL3与HDL-C(r=0.67,P<0.0001)和脂联素(r=0.57,P<0.0001)高度相关,但与CETP无关。
在平均日本人群中相比低CETP病例,HALT病例中ANGPTL3升高的异常频率更高。这些发现表明,作为内皮脂肪酶抑制剂的ANGPTL3可能与血浆中HDL-C升高的关联比CETP更为密切。因此,ANGPTL3似乎是调节HDL-C的更好靶点。